What Does a Vaginal Swab Test For?
A vaginal swab tests for the three most common causes of vaginitis: bacterial vaginosis (BV), vulvovaginal candidiasis (yeast infections), and trichomoniasis, and can also detect sexually transmitted infections including Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. 1
Primary Diagnostic Targets
According to the 2018 IDSA/ASM guidelines, vaginal swabs are specifically designed to evaluate:
The Three Main Vaginitis Causes:
Bacterial Vaginosis (BV) - characterized by altered vaginal flora with overgrowth of anaerobic bacteria, particularly Gardnerella vaginalis (vaginal pH >4.5) 1
Vulvovaginal Candidiasis (VVC) - fungal infection caused by Candida species, most commonly C. albicans, but also resistant species like C. glabrata and C. krusei (vaginal pH <4.5) 1
Trichomoniasis - sexually transmitted protozoal infection caused by Trichomonas vaginalis (vaginal pH >4.5) 1
Additional STI Detection:
The same vaginal swab specimen can simultaneously test for:
Recent evidence shows that vaginal swabs perform equivalently to endocervical samples for STI detection, with sensitivity of 96.5% and specificity of 100% 2.
Testing Methods Available
The guidelines outline multiple diagnostic approaches with varying accuracy 1:
Molecular Testing (Highest Accuracy):
- Multiplex nucleic acid amplification tests (NAATs) are now FDA-cleared and represent the most sensitive and specific approach, detecting all three vaginitis causes simultaneously 1
- Molecular tests achieve 90.5% sensitivity for BV, 90.9% sensitivity for Candida group, and 93.1% sensitivity for trichomoniasis 3
- These tests are microbiome-based and provide greater specificity than older methods that only detect G. vaginalis 1
Traditional Methods (Lower Sensitivity):
- Wet mount microscopy - only 40-70% sensitive for both yeast and trichomonads 1
- KOH preparation - for detecting fungal pseudohyphae
- Gram stain - most specific for BV diagnosis but requires technical expertise 1
- Culture - useful for recurrent cases or when microscopy is negative 1
Important Clinical Considerations
Self-Collection is Valid:
Multiple studies confirm that patient self-collected vaginal swabs are non-inferior to clinician-collected specimens for detecting all common vaginal infections 4, 5. Self-collection shows:
- 95.5% sensitivity for VVC detection
- 88.5% sensitivity for BV detection
- High patient acceptability (84% recommend this method) 4, 5
Multi-Pathogen Infections are Common:
Approximately 20% of symptomatic women have coinfections 3. Recent data shows multi-pathogen infection is associated with:
- Abnormal vaginal discharge (OR = 5.44)
- Itching (OR = 2.13)
- Elevated vaginal pH (OR = 4.70) 6
Critical Pitfall:
Point-of-care tests and traditional microscopy have poor sensitivity (40-80%) and should not be relied upon alone 1. The guidelines emphasize that while rapid tests are popular, they are "often diagnostically poor" 1. When available, molecular testing should be prioritized, especially since Trichomonas prevalence equals or exceeds chlamydia and gonorrhea in certain populations 1.
Screening Context:
In pregnant women, vaginal swabs also routinely screen for Group B Streptococcus (GBS) colonization, with self-collected swabs showing 13.4% detection rate versus 11.5% for clinician-collected 4.
The evidence strongly supports transitioning to multiplex molecular testing when feasible, as it provides objective, quantitative results that don't rely on viable organisms or technical expertise in microscopy 1, 3.